%0 Journal Article
%T Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial
%A Samalin, E
%A Bouché, O
%A Thézenas, S
%A Francois, E
%A Adenis, A
%A Bennouna, J
%A Taieb, J
%A Desseigne, F
%A Seitz, J F
%A Conroy, T
%A Galais, M P
%A Assenat, E
%A Crapez, E
%A Poujol, S
%A Bibeau, F
%A Boissière, F
%A Laurent-Puig, P
%A Ychou, M
%A Mazard, T
%J British Journal of Cancer
%V 110
%N 5
%P 1148-1154
%@ 0007-0920
%D 2014-01-09
%I Nature Publishing Group UK
%~ DeepDyve